|
The Bethesda system (TBS) is a system for reporting cervical or vaginal cytologic diagnoses,〔 used for reporting Pap smear results. It was introduced in 1988, and revised in 1991 and 2001.〔Nayar R, Solomon D. Second edition of 'The Bethesda System for reporting cervical cytology' – Atlas, website, and Bethesda interobserver reproducibility project. CytoJournal (online ) 2004 (2011 Apr 17 );1:4. Available from: http://www.cytojournal.com/text.asp?2004/1/1/4/41272〕 The name comes from the location (Bethesda, Maryland) of the conference that established the system. ==Types of results== Abnormal results include: *Atypical squamous cells * *Atypical squamous cells of undetermined significance (ASC-US) * *Atypical squamous cells – cannot exclude HSIL (ASC-H) *Low grade squamous intraepithelial lesion (LGSIL or LSIL) *High grade squamous intraepithelial lesion (HGSIL or HSIL) *Squamous cell carcinoma *Atypical Glandular Cells not otherwise specified (AGC-NOS) *Atypical Glandular Cells, suspicious for AIS or cancer (AGC-neoplastic) *Adenocarcinoma ''in situ'' (AIS) 抄文引用元・出典: フリー百科事典『 ウィキペディア（Wikipedia）』 ■ウィキペディアで「Bethesda system」の詳細全文を読む スポンサード リンク
|